Open Pilot Trial of BHV-4157

Status Active, not recruiting

Clinical Trial Summary

24 adults, between the ages of 18 and 75 years, with cerebellar ataxia will be enrolled in a 12 week trial of BHV-4157 for treatment of ataxia. BHV-4157 is a pro-drug of riluzole (which is currently FDA-approved for ALS, Lou Gehrig's disease). There will be 5 visits to UCLA required--Screening when general and neurological examination, blood and urine testing, ECG, and questionnaires will be administered; Baseline when general and neurological examination and questionnaires will be administered and study drug dispensed; Week 4 and Week 12 when general and neurological examination, blood and urine testing, ECG, and questionnaires will be administered; 2 weeks after finishing study drug when general examination and blood testing will be completed. There is an option for a 36 week extension of the study drug trial.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03408080
Study type	Interventional
Source	University of California, Los Angeles
Contact
Status	Active, not recruiting
Phase	Phase 3
Start date	December 15, 2017
Completion date	December 15, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05973019` - rTMS Improves Functions in Spinocerebellar Ataxia	N/A
Completed	`NCT04837027` - Effect of Training on Brain Volume in Ataxia	N/A
Completed	`NCT04595578` - Cerebellar rTMS and Physical Therapy for Cerebellar Ataxia	N/A
Completed	`NCT03745248` - Aerobic Exercise, Balance Training, and Ataxia	N/A
Completed	`NCT05951010` - Cerebellar Transcranial Direct Current Stimulation in Spinocerebellar Ataxia 38	N/A
Completed	`NCT01037777` - RISCA : Prospective Study of Individuals at Risk for SCA1, SCA2, SCA3, SCA6, SCA7
Completed	`NCT00136630` - Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations
Completed	`NCT03687190` - Could Tai-chi Help Maintain Balance of Spinocerebellar Ataxia Patients	N/A
Active, not recruiting	`NCT03701399` - Troriluzole in Adult Subjects With Spinocerebellar Ataxia	Phase 3
Completed	`NCT05436262` - Using Real-time fMRI Neurofeedback and Motor Imagery to Enhance Motor Timing and Precision in Cerebellar Ataxia	N/A
Recruiting	`NCT04231487` - Using Wearable and Mobile Data to Diagnose and Monitor Movement Disorders
Withdrawn	`NCT04301284` - Study of CAD-1883 for Spinocerebellar Ataxia	Phase 2
Not yet recruiting	`NCT06397274` - Stemchymal® for Polyglutamine Spinocerebellar Ataxia	Phase 2
Not yet recruiting	`NCT06177626` - Impact of Exercise on Eyeblink Conditioning in Spinocerebellar Ataxias	N/A
Recruiting	`NCT04529252` - Investigating the Genetic and Phenotypic Presentation of Ataxia and Nucleotide Repeat Diseases
Completed	`NCT05621200` - Transcranial Alternating Current Stimulation (tACS) in Patients With Ataxia	N/A
Completed	`NCT03701776` - Ataxia and Exercise Disease Using MRI and Gait Analysis	N/A
Completed	`NCT03120013` - Rehabilitative Trial With Cerebello-Spinal tDCS in Neurodegenerative Ataxia	N/A
Active, not recruiting	`NCT02960893` - Trial in Adult Subjects With Spinocerebellar Ataxia	Phase 2/Phase 3
Completed	`NCT04153110` - Cerebello-Spinal tDCS as Rehabilitative Intervention in Neurodegenerative Ataxia	N/A